eMedicine Specialties > Pediatrics: General Medicine > Endocrinology

Adrenal Hypoplasia: Differential Diagnoses & Workup

Author: Thomas A Wilson, MD, Professor of Clinical Pediatrics, Department of Pediatrics; Director of Pediatric Endocrinology, Division of Pediatric Endocrinology, Department of Pediatrics, State University of New York at Stony Brook
Contributor Information and Disclosures

Updated: Feb 18, 2009

Differential Diagnoses

17-Hydroxylase Deficiency Syndrome
Dehydration
5-Alpha-Reductase Deficiency
Denys-Drash Syndrome
Addison Disease
Familial Glucocorticoid Deficiency
Adrenal Crisis
Genital Anomalies
Adrenal Hemorrhage
Hyperkalemia
Adrenal Hypoplasia
Hypogonadism
Adrenal Insufficiency
Hyponatremia
Aldosterone synthase deficiency
Hypopituitarism (Panhypopituitarism)
Allgrove (AAA) Syndrome
Pseudohypoaldosteronism
C-17 Hydroxylase Deficiency
Smith-Lemli-Opitz Syndrome
Congenital Adrenal Hyperplasia

Other Problems to Be Considered

Addison disease
Adrenoleukodystrophy
Bilateral adrenal hemorrhage
Congenital unresponsiveness to adrenocorticotropic hormone (ACTH)
Hypoaldosteronism
Renal tubular disorders
46,XY sex reversal due to mutations in genes SRY, SOX9, WT1 (Denys-Drash Syndrome), and SF1

Workup

Laboratory Studies

The most difficult aspect of adrenal hypoplasia is clinical suspicion because signs and symptoms can be insidious and subtle.

  • When adrenal insufficiency is suspected, promptly obtain the following laboratory values:
    • Electrolytes
    • Blood sugar
    • Serum adrenocorticotropic hormone (ACTH)
    • Plasma-renin activity
    • Serum cortisol
    • Aldosterone
    • 17-hydroxyprogesterone
    • High-resolution karyotype
  • When hyponatremia or hyperkalemia are found, a spot urine test or a 24-hour urine test for sodium, potassium, and creatinine (along with simultaneous serum sodium concentrations and creatinine concentrations) determine whether inappropriate natriuresis is occurring (fractional excretion of sodium >1% in the face of hyponatremia). This occurs with mineralocorticoid deficiency when renal function is otherwise normal. A plasma renin activity (PRA)–to–aldosterone ratio of more than 30 is suggestive of inadequate mineralocorticoid production.
  • Random serum cortisol concentrations must be interpreted within the context in which they were obtained.
    • For example, in a healthy individual, an 8:00 am serum cortisol concentration higher than 10 mcg/dL makes adrenal insufficiency unlikely.
    • A serum cortisol concentration less than 18 mcg/dL in a sick and stressed patient is highly suggestive of adrenal insufficiency.
    • A serum cortisol concentration less than 18 mcg/dL in the presence of an elevated serum ACTH concentration and plasma renin activity confirms adrenal insufficiency. Serum cortisol less than 18 mcg/dL obtained 30-60 minutes following cosyntropin is confirmatory.17
    • These guidelines do not apply to premature infants and infants with low birth weight who have lower cortisol secretion and, most likely, decreased cortisol binding to carrier proteins.18 The diagnosis of adrenal insufficiency in premature infants remains problematic.
  • Measure a panel of adrenal cortical hormones either with or without prior cosyntropin stimulation to exclude the various forms of congenital adrenal hyperplasia.
  • A cosyntropin stimulation test can confirm the diagnosis of adrenocortical insufficiency.
    • Controversy surrounds whether the best dose of cosyntropin is the standard dose (250 mcg for an adult) or the low dose (1 mcg or 0.5 mcg/m2), which some have advocated as more sensitive for central adrenal insufficiency. A meta-analysis suggested that the low dose cosyntropin stimulation test is superior, but the difference was small.19  This issue remains unresolved in the pediatric age group. 
    • Because dilution of cosyntropin to 1 mcg is cumbersome and prone to error, and because all the above doses are probably supraphysiologic, the author generally uses the standard dose or empirically adjusts the dose for patient size (25 mcg for an infant, 50 mcg for a young child, 100 mcg for an older child, and 250 mcg for an adolescent or adult).
    • When a patient's serum cortisol response to cosyntropin is subnormal but his or her serum ACTH level is not elevated, the possibility of central adrenal insufficiency should be considered. Other indications of pituitary dysfunction such as prior glucocorticoid exposure (suggesting a suppressed hypothalamic-pituitary-adrenal axis) or evidence of other pituitary dysfunction are helpful clues suggesting ACTH deficiency. 
    • In central adrenal insufficiency, 3 days of stimulation with ACTH produces a normal cortisol response, indicating intact adrenal glands and implying that the initial low cortisol response to cosyntropin was related to chronic ACTH deficiency. ACTH gel (ACTHar Gel) is administered at 25 U/m2 every 12 hours for 3 days. Plasma cortisol levels should increase to more than 40 mcg/dL in response. This procedure is now seldom performed
  • The standard ovine corticotropin-releasing hormone (CRH) stimulation test (1 mcg/kg over 1 min) may be helpful in the differential diagnosis of adrenal insufficiency. 
    • A lack of a 2-fold increase in serum ACTH concentration indicates pituitary dysfunction. A 2-fold or greater rise in ACTH levels without a concomitant rise in serum cortisol to more than 18-20 mcg/dL implies primary adrenal insufficiency.20
    • Ovine CRH is difficult to obtain, and this test is mainly done for research purposes.
  • In the most common form of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency, serum 17-hydroxyprogesterone is markedly elevated.
  • Consider adrenoleukodystrophy (OMIM 300100) in older boys with evidence of adrenal insufficiency. Both males and females may be affected with autoimmune Addison disease, another important diagnostic consideration.
    • Adrenal leukodystrophy is also X-linked and can be diagnosed by demonstrating elevated concentrations of very–long-chain fatty acids (>24 carbon) in serum.
    • Autoimmune Addison disease is confirmed by the demonstration of antiadrenal antibodies in the serum.
  • Karyotype, fluorescent in situ hybridization (FISH) or microarray analysis may reveal the gene deletion involving DAX1.
  • Prenatal diagnosis is possible.21

Imaging Studies

  • CT is the best imaging study for the adrenal gland. It excludes the possibility of bilateral adrenal hemorrhage, which can present with an identical clinical picture. However, CT cannot exclude congenital adrenal hypoplasia due to a DAX1 deletion in an infant because the fetal adrenal zone is preserved in this condition.
  • Abdominal ultrasonography identifies adrenal glands in infants due to the large fetal zone; however, it usually is not helpful in older children.

Other Tests

  • Gene studies of the DAX1 gene on the X chromosome or fluorescent in situ hybridization (FISH), using an appropriate complimentary DNA (cDNA) probe to the region containing DAX1, confirms the existence of a deletion in the DAX1 region of the X chromosome.

Histologic Findings

  • The 2 described forms of congenital adrenal hypoplasia differ in anatomic findings.
    • The X-linked form is associated with hypoplasia of the definitive adult zone of the adrenal cortex with preservation of the fetal zone. Histologically, the adrenal cortex is disorganized and the cells are cytomegalic.
    • The autosomal recessive form is associated with absence of the fetal zone and severe hypoplasia of the definitive adult adrenal zone. This is often referred to as the miniature type because of the hypoplastic adrenal cortex.
  • Congenital adrenal hypoplasia due to SF1 defect is associated with gonadal dysgenesis (streak gonad, gonad replaced by fibrous material).

More on Adrenal Hypoplasia

Overview: Adrenal Hypoplasia
Differential Diagnoses & Workup: Adrenal Hypoplasia
Treatment & Medication: Adrenal Hypoplasia
Follow-up: Adrenal Hypoplasia
References

References

  1. Fujieda K, Tajima T. Molecular basis of adrenal insufficiency. Pediatr Res. May 2005;57(5 Pt 2):62R-69R. [Medline].

  2. Ferraz-de-Souza B, Achermann JC. Disorders of adrenal development. Endocr Dev. 2008;13:19-32. [Medline].

  3. Kempná P, Flück CE. Adrenal gland development and defects. Best Pract Res Clin Endocrinol Metab. Feb 2008;22(1):77-93. [Medline].

  4. NCBI. Online Mendelian Inheritance in Man, OMIM (TM). Available at http://www.ncbi.nlm.nih.gov/omim/.

  5. Habiby RL, Boepple P, Nachtigall L, et al. Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypothalamic and pituitary defects in gonadotropin production. J Clin Invest. Aug 15 1996;98(4):1055-62. [Medline].

  6. Achermann JC, Ito M, Ito M, et al. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat Genet. Jun 1999;22(2):125-6. [Medline].

  7. Bergada I, Del Rey G, Lapunzina P, et al. Familial occurrence of the IMAGe association: additional clinical variants and a proposed mode of inheritance. J Clin Endocrinol Metab. Jun 2005;90(6):3186-90. [Medline][Full Text].

  8. McCabe ER. DAX1: Increasing complexity in the roles of this novel nuclear receptor. Mol Cell Endocrinol. Feb 2007;265-266:179-82. [Medline].

  9. Lin L, Gu WX, Ozisik G, et al. Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (SF1/Ad4BP, NR5A1) in children and adults with primary adrenal failure: ten years' experience. J Clin Endocrinol Metab. May 9 2006;[Medline][Full Text].

  10. Manna PR, Dyson MT, Jo Y, Stocco DM. Role of dosage-sensitive sex reversal, adrenal hypoplasia congenita, critical region on the X chromosome, gene 1 in protein kinase A- and protein kinase C-mediated regulation of the steroidogenic acute regulatory protein expression in mouse Leydig tumor cells: mechanism of action. Endocrinology. Jan 2009;150(1):187-99. [Medline].

  11. Merke DP, Tajima T, Baron J, Cutler GB Jr. Hypogonadotropic hypogonadism in a female caused by an X-linked recessive mutation in the DAX1 gene. N Engl J Med. Apr 22 1999;340(16):1248-52. [Medline].

  12. Peter M, Viemann M, Partsch CJ, Sippell WG. Congenital adrenal hypoplasia: clinical spectrum, experience with hormonal diagnosis, and report on new point mutations of the DAX-1 gene. J Clin Endocrinol Metab. Aug 1998;83(8):2666-74. [Medline].

  13. Schwarz K, Thwaites R, Minford A, et al. Congenital adrenal hypoplasia presenting as a chronic respiratory condition. Arch Dis Child. Mar 2003;88(3):261-2. [Medline].

  14. Reutens AT, Achermann JC, Ito M, et al. Clinical and functional effects of mutations in the DAX-1 gene in patients with adrenal hypoplasia congenita. J Clin Endocrinol Metab. Feb 1999;84(2):504-11. [Medline].

  15. Kaiserman KB, Nakamoto JM, Geffner ME, McCabe ER. Minipuberty of infancy and adolescent pubertal function in adrenal hypoplasia congenita. J Pediatr. Aug 1998;133(2):300-2. [Medline].

  16. Parker KL, Schimmer BP. Steroidogenic factor 1: a key determinant of endocrine development and function. Endocr Rev. Jun 1997;18(3):361-77. [Medline].

  17. Lashansky G, Saenger P, Fishman K, et al. Normative data for adrenal steroidogenesis in a healthy pediatric population: age- and sex-related changes after adrenocorticotropin stimulation. J Clin Endocrinol Metab. Sep 1991;73(3):674-86. [Medline].

  18. Heckmann M, Hartmann MF, Kampschulte B, et al. Cortisol production rates in preterm infants in relation to growth and illness: a noninvasive prospective study using gas chromatography-mass spectrometry. J Clin Endocrinol Metab. Oct 2005;90(10):5737-42. [Medline].

  19. Kazlauskaite R, Evans AT, Villabona CV, et al. Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysis. J Clin Endocrinol Metab. Nov 2008;93(11):4245-53. [Medline].

  20. Schurmeyer TH, Avgerinos PC, Gold PW, et al. Human corticotropin-releasing factor in man: pharmacokinetic properties and dose-response of plasma adrenocorticotropin and cortisol secretion. J Clin Endocrinol Metab. Dec 1984;59(6):1103-8. [Medline].

  21. Peter M, Partsch CJ, Dorr HG, Sippell WG. Prenatal diagnosis of congenital adrenal hypoplasia. Horm Res. Jul 1996;46(1):41-5. [Medline].

Further Reading

Keywords

adrenal hypoplasia congenita, adrenal insufficiency, congenital adrenal hypoadrenalism, hypoplasia, primary adrenal hypoplasia, hypogonadotropic hypogonadism, Duchenne muscular dystrophy, glycerol kinase deficiency, intrauterine growth retardation, metaphysial dysplasia, hyperglycerolemia, sensorineural deafness, dehydration, hyponatremia, hyperkalemia, hypotension, hypoglycemia, micropenis, hypospadias, cryptorchidism, hearing loss

Contributor Information and Disclosures

Author

Thomas A Wilson, MD, Professor of Clinical Pediatrics, Department of Pediatrics; Director of Pediatric Endocrinology, Division of Pediatric Endocrinology, Department of Pediatrics, State University of New York at Stony Brook
Thomas A Wilson, MD is a member of the following medical societies: Endocrine Society, Lawson-Wilkins Pediatric Endocrine Society, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Medical Editor

Phyllis W Speiser, MD, Chief of Pediatric Endocrinology, Schneider Children's Hospital; Professor of Pediatrics, New York University School of Medicine
Phyllis W Speiser, MD is a member of the following medical societies: American Association of Clinical Endocrinologists, Endocrine Society, Lawson-Wilkins Pediatric Endocrine Society, and Society for Pediatric Research
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from financial planner; Avanir Pharma Stock Investment from financial planner ; WebMD Salary and stock Employment and investment from financial planner

Managing Editor

Barry B Bercu, MD, Professor, Departments of Pediatrics, Molecular Pharmacology and Physiology, University of South Florida College of Medicine, All Children's Hospital
Barry B Bercu, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Clinical Endocrinologists, American Federation for Clinical Research, American Medical Association, American Pediatric Society, Association of Clinical Scientists, Endocrine Society, Florida Medical Association, Lawson-Wilkins Pediatric Endocrine Society, Pituitary Society, Society for Pediatric Research, Society for the Study of Reproduction, and Southern Society for Pediatric Research
Disclosure: Nothing to disclose.

CME Editor

Merrily P M Poth, MD, Professor, Department of Pediatrics and Neuroscience, Uniformed Services University of the Health Sciences
Merrily P M Poth, MD is a member of the following medical societies: American Academy of Pediatrics, Endocrine Society, and Lawson-Wilkins Pediatric Endocrine Society
Disclosure: Nothing to disclose.

Chief Editor

Stephen Kemp, MD, PhD, Professor, Department of Pediatrics, Section of Pediatric Endocrinology, University of Arkansas and Arkansas Children's Hospital
Stephen Kemp, MD, PhD is a member of the following medical societies: American Academy of Pediatrics, American Association of Clinical Endocrinologists, American Pediatric Society, Endocrine Society, Phi Beta Kappa, Southern Medical Association, and Southern Society for Pediatric Research
Disclosure: Genentech, Inc. Honoraria Speaking and teaching; Pfizer, Inc. Honoraria Consulting

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.